These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2300507)

  • 1. Problems associated with the administration of intraperitoneal therapy using the Port-A-Cath system.
    Almadrones L; Yerys C
    Oncol Nurs Forum; 1990; 17(1):75-80. PubMed ID: 2300507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications associated with intraperitoneal chemotherapy catheters.
    Makhija S; Leitao M; Sabbatini P; Bellin N; Almadrones L; Leon L; Spriggs DR; Barakat R
    Gynecol Oncol; 2001 Apr; 81(1):77-81. PubMed ID: 11277654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes associated with different intraperitoneal chemotherapy delivery systems in advanced ovarian carcinoma: a single institution's experience.
    Ivy JJ; Geller M; Pierson SM; Jonson AL; Argenta PA
    Gynecol Oncol; 2009 Sep; 114(3):420-3. PubMed ID: 19560189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
    Lan C; Li Y; Liu J
    Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer.
    Malmström H; Carstensen J; Simonsen E
    Gynecol Oncol; 1994 Jul; 54(1):27-34. PubMed ID: 8020835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters.
    Henretta MS; Anderson CL; Angle JF; Duska LR
    Gynecol Oncol; 2011 Nov; 123(2):342-5. PubMed ID: 21840583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
    Kehoe SM; Williams NL; Yakubu R; Levine DA; Chi DS; Sabbatini PJ; Aghajanian CA; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2009 May; 113(2):228-32. PubMed ID: 19254808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Berry E; Matthews KS; Singh DK; Buttin BM; Lurain JR; Alvarez RD; Schink J
    Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Walker JL; Armstrong DK; Huang HQ; Fowler J; Webster K; Burger RA; Clarke-Pearson D
    Gynecol Oncol; 2006 Jan; 100(1):27-32. PubMed ID: 16368440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
    Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S
    Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic intraperitoneal port placement for optimally cytoreduced advanced ovarian cancer.
    Janco JM; Hacker MR; Konstantinopoulos PA; Cannistra SA; Awtrey CS
    J Minim Invasive Gynecol; 2011; 18(5):629-33. PubMed ID: 21803662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.
    Makhija S; Sabbatini P; Aghajanian C; Venkatraman E; Spriggs DR; Barakat R
    Gynecol Oncol; 2000 Oct; 79(1):28-32. PubMed ID: 11006026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates.
    Landrum LM; Gold MA; Moore KN; Myers TK; McMeekin DS; Walker JL
    Gynecol Oncol; 2008 Feb; 108(2):342-7. PubMed ID: 17988721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
    Black D; Levine DA; Nicoll L; Chou JF; Iasonos A; Brown CL; Sonoda Y; Chi DS; Leitao MM; Abu-Rustum NR; Ferguson SE; Barakat RR
    Gynecol Oncol; 2008 Apr; 109(1):39-42. PubMed ID: 18234300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of infections related to intraperitoneal catheters in patients with ovarian cancer.
    Meunier F; van der Auwera P; Aoun M; Piccart M; Sculier JP
    Scand J Infect Dis Suppl; 1990; 72():26-8. PubMed ID: 2151063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
    Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
    Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of a Tenckhoff catheter in ovarian cancer].
    Kato N; Arakawa A; Yasui Y; Suzumori K; Suzumori K; Yagami Y
    Gan To Kagaku Ryoho; 1991 May; 18(6):1025-30. PubMed ID: 2029187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
    Naumann RW; Alvarez RD; Partridge EE; Kilgore LC; Austin JM
    Gynecol Oncol; 1993 Sep; 50(3):291-3. PubMed ID: 8406189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors].
    Shimizu A; Kimura T; Funatsu M; Hada Y; Tamura K; Taguchi A; Miyakawa Z; Notake Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1738-41. PubMed ID: 1530345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications.
    Lesnock JL; Richard SD; Zorn KK; Krivak TC; Beriwal S; Sukumvanich P; McBee WC; Kelley JL; Edwards RP
    Gynecol Oncol; 2010 Mar; 116(3):345-50. PubMed ID: 19959211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.